Systemic Sclerosis (SSc)
Immunology·MeSH: Lung Diseases, Interstitial
Prevalence
30.0 / 100K
4 drugs in development·4 companies·10 clinical trials
Drug Pipeline by Phase
Phase 2(3)
Phase 1(1)
| Drug | Company |
|---|---|
| prula-cel | Adicet Bio, Inc. (ACET) |
Compare drugs
Frequently asked questions
How many drugs are in development for Systemic Sclerosis (SSc)?
BioSniper tracks 4 drugs in development for Systemic Sclerosis (SSc) across 4 companies.
How many clinical trials target Systemic Sclerosis (SSc)?
There are 10 clinical trials targeting Systemic Sclerosis (SSc) tracked by BioSniper.
What is the prevalence of Systemic Sclerosis (SSc)?
The estimated prevalence of Systemic Sclerosis (SSc) is approximately 30.0 per 100,000 population.
Deep-dive into Systemic Sclerosis (SSc)
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis